Navigation Links
Rheumatologists Underestimate the Patients Ability to Work

Researchers at University of south Florida has found that Rheumatologists substantially overestimate the physical disability of patients with rheumatoid arthritis which may lead to inaccurate evaluations of the patients ability to work and need for lifestyle modifications.

The rheumatologists consistently rated their rheumatoid arthritis patients degree of difficulty in performing activities of daily living, such as walking, dressing and eating, higher than the patients themselves. This was particularly true for patients in advanced stages of the disease.

We flunked, said co-first author John D. Carter, MD, assistant professor of medicine in the USF Division of Rheumatology. The very physicians deemed to be experts in rheumatoid arthritis failed to make the grade when it came to determining their patients functional status.

This discrepancy is important to correct because patients can rely on these assessments for their livelihood or other necessities to perform activities of daily living.

Rheumatologists are frequently asked to complete functional disability reports by employers, disability attorneys, insurance companies and government agencies weighing a persons eligibility for disability payments, employment, or assistive devices such as wheelchairs, walkers, braces and splints.

Using the Stanford Health Assessment Questionnaire-Disability Index (HAQ-DI), rheumatologists evaluated 223 patients during their regularly scheduled visits to the USF Rheumatology Clinics and James A. Haley Veterans Hospital.

The effectiveness of the HAQ-DI, based on patient self-reporting of their disability status, has been validated in clinical studies. The questionnaire covers eight activities of daily living: dressing, arising, eating, hygiene, walking, reach, grip and outside activity.

Both physician and patient completed the HAQ-DI independently immediately following the visit and the ir respective scores were not shared.

The rheumatologists overestimated the degree of functional disability in 154, or 69 percent, of the 223 the patients. However, they were significantly more accurate at determining the degree of physical limitations in patients with less severe disease.

The reasons for the overestimation are unclear, but may include empathy and suggest that even patients with advanced rheumatoid arthritis adapt their activities to the progression of the chronic disease, Dr. Carter said. We tend to associate visible joint deformities with incapacitated function, but patients may actually be more capable than we think.

Rheumatologists typically determine functional disability based on the patients examination and medical history, but these impressions during routine care are inadequate, Dr. Carter said.

The study points to the need for a formal, standardized evaluation, such as the HAQ-DI. It needs to be reimbursable and include input from physical and occupational therapists who could add valuable insight to the process of evaluating disability, he added.

Rheumatoid arthritis affects about 2.1 million Americans, or 1 percent of the population. Over the last decade new drugs have revolutionized the treatment of this debilitating inflammatory disease, but nearly all patients with rheumatoid arthritis eventually develop some degree of work or daily lifestyle disability, often severe.


'"/>




Related medicine news :

1. Breast Cancer in Men Often Underestimated and Under-treated
2. Importance of Retroviral Drugs Underestimated
3. Number of Heat-Related Deaths is Underestimated by Over 50%
4. Biopsy may Underestimate Prostate Cancer in Obese and Overweight Men
5. One in Three Heart Attack Patients Have No Chest Pains
6. Amphetamines Help Recovery of Stroke Patients
7. Painkillers Do Not Shorten Dying Patients Lives
8. Patients With Filariasis More Prone To HIV Infection
9. Glivec - New Hope For CMC Patients
10. Patients often assume wrongly that they are allergic to penicillin
11. New FDA Approved Drug NATRECOR For Heart Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... ... February 09, 2016 , ... Dr. Rassouli, cosmetic dentist ... whitening is among the most popular cosmetic procedures in dentistry today, but the cost ... can put them at risk of teeth whitening-related damage. For a limited time, Dr. ...
(Date:2/9/2016)... ... , ... Two renowned photographers, Robert Caplin (New York, NY) and Peter Lockley ... 14-19, 2016, hosted by Four Seasons Resort Maui at Wailea as part of the ... 2015, the Maui Photo Expedition workshop will once again consist of on-location ...
(Date:2/9/2016)... ... 09, 2016 , ... Shark Finds and Kevin Harrington, and the Product Managers of ... GRIP-DRY is a newly patented product that has solved some of the basic problems golfers ... early morning dew or right after a rain shower, might understand the struggle of placing ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... with BASF Human Nutrition into the Food & Beverage and ... been BASF’s channel partner throughout Canada and USA geographies east of the Rocky ...
(Date:2/8/2016)... Angeles, CA (PRWEB) , ... February 08, 2016 , ... A man who has struggled ... of Freedom Laser Therapy , was determined to find solutions to his problems – ... of Inventors Digest is ready to introduce his breakthrough inventions to the world ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 2016  Landauer, Inc. (NYSE: LDR ), a ... monitoring, outsourced medical physics services and high quality medical ... 2016 first quarter ended December 31, 2015. ... First Quarter Highlights , Revenue of $36.5 million ... 2015 , Domestic Radiation Measurement services revenues increased 2.8% ...
(Date:2/9/2016)... -- Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... fourth quarter and full year 2015 financial results ... genome editing," said Edward Lanphier, Sangamo,s president and ... technology leads the therapeutic genome editing field and ... move our ground-breaking genome editing programs through IND ...
(Date:2/9/2016)... QGEN ; Frankfurt Prime ... Genomics to develop and promote comprehensive solutions for ... --> QGEN ; Frankfurt Prime Standard: QIA) ... develop and promote comprehensive solutions for next-generation sequencing ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ...
Breaking Medicine Technology: